Marco Munoz
Family Medicine · Fort Worth, TXNPI 1356659585
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.2% of the total across 113 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 20.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $928 and has fallen 98.5% since, to $14 in 2024.
Across 113 payments — averaging $11.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$268
- Novo Nordisk$203
- AstraZeneca$160
- Amgen$157
- Merck$88
- Teva Pharmaceuticals USA, Inc.$86
- plus $353 from 13 others
What the payments were for
- Food & beverage$1,29198%
- Education$242%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 38 | $268 |
| Novo Nordisk | 22 | $203 |
| AstraZeneca | 9 | $160 |
| Amgen | 9 | $157 |
| Merck | 7 | $88 |
| Teva Pharmaceuticals USA, Inc. | 6 | $86 |
| Sanofi-aventis U.S. LLC | 4 | $64 |
| AbbVie(2 entities) | 3 | $43 |
| Pfizer | 2 | $41 |
| Genentech USA, Inc. | 2 | $34 |
| Novartis | 2 | $32 |
| Amarin Pharma, Inc. | 2 | $29 |
| Phadia US Inc. | 1 | $20 |
| Eisai Inc. | 1 | $19 |
| Regeneron Healthcare Solutions, Inc. | 1 | $17 |
| Exact Sciences | 1 | $14 |
| Mission Pharmacal Company | 1 | $14 |
| Arbor Pharmaceuticals, Inc. | 1 | $12 |
| E.r. Squibb & Sons, L.L.C. | 1 | $12 |
How this compares
$1,315 in reported general payments places this provider in the 65th percentile of 8,760 family medicine providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 15 | $177 |
| Amlodipine Besylate | 20 | $162 |
| Metformin Hcl | 11 | $94 |
| Lisinopril | 17 | $93 |
| Levothyroxine Sodium | 13 | $62 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Fort Worth
- Robert CampbellFort Worth$318K
- Kenton MurthyFort Worth$40K
- Peter DamicoFort Worth$37K
- Carlos CamposNew Braunfels$1.5M
- Aaron KingSan Antonio$1.1M
- Bradley WassonArlington$734K
- Cynthia BrinsonAustin$402K
- Michael MendezLubbock$368K
- Sang Tae KimAmarillo$368K
- Sumit PerakathuHarlingen$342K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.